Delivery Order SPE2DB20D2104-SPE2DB24FS24R

Award Date 1/26/24
Potential Completion Date 1/29/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Forteo 600 mcg/2.4 ml injection pens. The contract has a firm fixed price of $1,772.06 and an ultimate completion date of May 20, 2024. The contract is not set aside and was awarded on a full and open competition basis. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 600 MCG/2.4 ML pen injections. The contract has a ceiling value of $4,725.07 and an ultimate completion date of March 8, 2023. The contract is a firm fixed price delivery order, with no set-aside designation, indicating the award was made through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Forteo 600 mcg/2.4 ml pen injectable. The contract has a ceiling value of $2,977.19 and an ultimate completion date of January 31, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of Forteo 600 mcg/2.4 ml pen injections, with a potential value of $5,316.18 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,098.66 firm fixed-price contract is for the supply of Forteo 600 mcg/2.4 mL pen injection, a medication used to treat osteoporosis. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract worth $6,027.24 for the supply of Forteo 600 mcg/2.4 mL pen injections. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,657.62, is for the delivery of Forteo 600 mcg/2.4 ml pen injections to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has a firm fixed price and an ultimate completion date of...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, the Corporate Office division of pharmaceutical distributor Amerisourcebergen Corporation. The $3,544.12 firm fixed price contract is for the supply of Forteo 600 mcg/2.4 ml pen injections to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Forteo 600 mcg/2.4 ml pen injections. The contract has a ceiling value of $4,376.93 and a completion date of July 10, 2024. The contract is a firm fixed price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is one of the largest pharmaceutical distribution...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $39,486.28 firm fixed-price contract is for the delivery of Forteo 600 mcg/2.4 ml pen injections, a specialty medication. The contract has a completion date of September 17, 2024 and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FS24R
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 600 mcg/2.4 ml pen injections. The firm-fixed-price contract has a ceiling value of $1,772.06 and an ultimate completion date of January 29, 2024. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 12:39 PM